Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 10 points (-0.1%) at 16,415 as of Thursday, April 17, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,581 issues advancing vs. 1,369 declining with 186 unchanged. The Materials & Construction industry currently sits down 0.1% versus the S&P 500, which is unchanged. On the negative front, top decliners within the industry include Vulcan Materials Company ( VMC), down 1.8%, NVR ( NVR), down 1.3%, Republic Services ( RSG), down 1.1% and Weyerhaeuser ( WY), down 0.6%. TheStreet would like to highlight 3 stocks pushing the industry lower today: 3. DR Horton ( DHI) is one of the companies pushing the Materials & Construction industry lower today. As of noon trading, DR Horton is down $0.45 (-2.1%) to $21.41 on light volume. Thus far, 2.3 million shares of DR Horton exchanged hands as compared to its average daily volume of 7.1 million shares. The stock has ranged in price between $21.35-$21.86 after having opened the day at $21.85 as compared to the previous trading day's close of $21.86. D.R. Horton, Inc. operates as a homebuilding company. It is engaged in the acquisition and development of land; and construction and sale of residential homes in 27 states and 78 markets in the United States under the D.R. Horton, America's Builder, Emerald Homes, and Breland Homes. DR Horton has a market cap of $7.0 billion and is part of the industrial goods sector. Shares are down 2.1% year-to-date as of the close of trading on Wednesday. Currently there are 7 analysts that rate DR Horton a buy, 1 analyst rates it a sell, and 5 rate it a hold. TheStreet Ratings rates DR Horton as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, increase in net income, attractive valuation levels, good cash flow from operations and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full DR Horton Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.